ZAI LAB (09688) issued 11.7647 million shares according to the underwriting agreement.
Reign Pharmaceutical (09688) announced that, according to the underwriting agreement, the sale will take place on November 19, 2024 (USA time)...
ZAI LAB (09688) announced that, according to the underwriting agreement, a total of 11.7647 million new shares will be issued and distributed as part of the options American Depositary Shares related to the exercise by underwriters on November 19, 2024 (Eastern Time).
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
